ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
US Tech 100
19,168.00
0.52%
Dow Jones
38,589.16
-0.15%
Brent Oil
82.275
0.00%
Bitcoin
66,265.63
0.39%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. LENZ Therapeutics Inc (LENZ) Quote

LENZ Therapeutics Inc

LENZ Therapeutics Inc (LENZ)

Sancus Lending Group Limited
18.54
-0.09
(-0.48%)
Closed June 15 4:00PM
Delayed by 15 minutes
18.54
-0.03
(-0.16%)
After Hours: 5:30PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
18.54
Bid
18.00
Ask
19.00
Volume
127,008
17.89 Day's Range 19.48
14.42 52 Week Range 24.59
Market Cap
474.175M
Previous Close
18.63
Open
17.89
Last Trade
71
@
18
Last Trade Time
Financial Volume
$ 2,351,537
VWAP
18.5149
Average Volume (3m)
159,903
Shares Outstanding
25,534,458
Dividend Yield
-
PE Ratio
-3.80
Earnings Per Share (EPS)
-4.88
Revenue
-
Net Profit
-124.65M

About LENZ Therapeutics Inc

Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert ... Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations. Its lead product candidate GPH101 is a differentiated approach with the potential to directly correct the mutation that causes sickle cell disease (SCD) and restore normal adult hemoglobin (HgbA) expression. All of the company's long-lived assets are based in the United States. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.lenz-tx.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
LENZ Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker LENZ. The last closing price for LENZ Therapeutics was $18.63. Over the last year, LENZ Therapeutics shares have traded in a share price range of $ 14.42 to $ 24.59.

LENZ Therapeutics currently has 25,534,458 shares outstanding. The market capitalization of LENZ Therapeutics is $474.17 million. LENZ Therapeutics has a price to earnings ratio (PE ratio) of -3.80.

LENZ Latest News

More News

LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024

Capstone data from Phase 3 CLARITY study to be presented Event to feature Key Opinion Leader and Principal Investigator perspectives on LNZ100 potential in presbyopia SAN DIEGO, June 10, 2024...

June 10 2024
GlobeNewswire Inc.

LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference

SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first...

May 30 2024
GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans

May 21 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

May 09 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 08 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 08 2024
Edgar (US Regulatory)

LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Reported positive topline data from Phase 3 CLARITY study for presbyopia; selected LNZ100 as lead candidate; New Drug Application submission anticipated in mid-2024 Capstone data from Phase 3...

May 08 2024
GlobeNewswire Inc.

LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024

SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first...

May 01 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.523.271276595715.0419.9814.920118080618.20107304CS
42.0412.363636363616.519.9814.4218093716.6259816CS
122.5616.020025031315.9824.5914.4215990317.23023385CS
262.5616.020025031315.9824.5914.4215990317.23023385CS
522.5616.020025031315.9824.5914.4215990317.23023385CS
1562.5616.020025031315.9824.5914.4215990317.23023385CS
2602.5616.020025031315.9824.5914.4215990317.23023385CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M

Discussion

View Full Feed
janice shell janice shell 4 minutes ago
Oh yeah. Chip Roy is such a sterling character.
LuckyLovie LuckyLovie 4 minutes ago
Swamps why do u have to hold this poor girls arm to stay in the picture frame...lol...you've been buying pennie pigs for years cause your a broke joke...look at your attire in your pixs to prove my assessment of you,Let Me Guess You shop at SAVERS OR SALVATION ARMY...you & fish got that other Chines
RONN
Wise Man Wise Man 7 minutes ago
The Supreme Court put the prerequisite "Rehabilitate FnF" in its interpretation of the conservator's Incidental Power, and that's captured in the "authorized by this section", in:
Take any action authorized by this section, ...
https://investorshub.advfn.com/uimage/uploads/2024/4/29/c
FNMA
ignatiusrielly35 ignatiusrielly35 8 minutes ago
😂
GME
Phill-lecup Phill-lecup 9 minutes ago
***** Ivman (1virginman) will ftd in the friend category. An absolute legend for the incel community. Well done, community legend.

Not enough said about this queen.
GME
janice shell janice shell 9 minutes ago
Welfare offices and other agencies in 49 US states are providing voter registration forms to migrants without requiring proof of citizenship, leading Republicans and conservatives to call for swift federal action to stop the handouts.

Bullshit. They are not. And here's a bit more news
bluefish1 bluefish1 12 minutes ago
They're all drunk on the Max SRMX Kool-Aid. It causes reduced discretionary and reasoning skills, as well as extreme delusion and burying your head in literal sand.
They think they see a light at the end of the tunnel, but don't realize it's an oncoming train.

Pumpers are noto
SRMX
Rubyred77 Rubyred77 12 minutes ago
If there truly IS nothing, then why are you here wasting your time on this ticker?

Right………
AVXL
DD_dempsey DD_dempsey 12 minutes ago
Ty kindly with $RONN-

I have a feel we see a strong week forthcoming as we get closer to the next Corp update on the MOU.

As I see from the session- This tested .006-.0063 pps and retreated before heating up into the close. That’s a very good indicator for next week
RONN
ignatiusrielly35 ignatiusrielly35 12 minutes ago
You should find a real job, son. Posting the same repetitive, superficial FUD from your parents’ basement is not a career. What I mainly find offensive is your lack of effort and/or knowledge. Mr. Sugar Pill.

You are up to, what, 30 posts per day of the same crappola? I could easily t
AVXL
bradford86 bradford86 16 minutes ago
Huge fan of yours
FNMA
sylvia07 sylvia07 19 minutes ago
I think we are getting close to buyout!
RNLX
Jimmy Joe Jimmy Joe 20 minutes ago
imo the current government and i mean both parties need to go away. money rules and they are all on their payroll.

Yep, and guys like Kenny, Dougie, Jamie, Josh Woods, and that other Citadel creep who decides HALTS on the LULD advisory committee all need to spend time on Alcatraz unde
AMC
wallstreet1231 wallstreet1231 20 minutes ago
Price targets 60 days out? Tia
CNNA
Value_Investor Value_Investor 21 minutes ago
TTNXP was Up over 21% in After-Hour session on June 13 after Good News (see the link below)! Last January it did Quickly surge 5.2-Bagger to Pre-R/S's $1.456 from Pre-R/S's $0.28 --- see the first chart below!

https://www.otcmarkets.com/filing/html?id=17619193&guid=cqQ-kamb8r4T4rh
TNXP
CanItBThisEZ2Make CanItBThisEZ2Make 22 minutes ago
BEST SELLERS RANK (BSR) IS 768 42 Estimated Sold on Amazon Since APRIL 1 - 2nd Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value D
SRMX
Value_Investor Value_Investor 22 minutes ago
TTNXP was Up over 21% in After-Hour session on June 13 after Good News (see the link below)! Last January it did Quickly surge 5.2-Bagger to Pre-R/S's $1.456 from Pre-R/S's $0.28 --- see the first chart below!

https://www.otcmarkets.com/filing/html?id=17619193&guid=cqQ-kamb8r4T4rh
TNXP
NICKSCA123 NICKSCA123 23 minutes ago
HQGE is the one. This one will make people with patience a lot of money
HQGE
kund kund 23 minutes ago
Two delusional pumpers consoling each other on weekend... There is nothing in this POS. Your clown CEO is already on vacation. He will fly in for the AGM, then go back on vacation. Dreams are free; keep dreaming.
AVXL
DD_dempsey DD_dempsey 27 minutes ago
$SMCE- Check this post and the timing out it-

I write this to you specifically because you brought up a crucial element. The dilutive overhang is what generally makes charting on BB a challenge. The way debt can be hidden and already in OS- it’s not always easy for retail chartist
SMCE
janice shell janice shell 31 minutes ago
You are SO right! THANK YOU for opening our eyes!!

Your Recent History

NASDAQ
LENZ
LENZ Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved